• Title of article

    Oral allopurinol desensitization

  • Author/Authors

    Kolahi ، Sousan نويسنده , , Tajeddini، Mahdi نويسنده 1Connective Tissue Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Tajeddini, Mahdi , Jalilzadeh Binazar، Mehran نويسنده Student Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Jalilzadeh Binazar, Mehran

  • Issue Information
    روزنامه با شماره پیاپی سال 2014
  • Pages
    2
  • From page
    32
  • To page
    33
  • Abstract
    Allopurinol, a xanthine oxidase inhibitor, is an effective urate-lowering drug. Unlike majority of patients tolerate allopurinol well, in 2% of patients receiving allopurinol, hypersensitivity reactions have been reported. In this case a 71-year-old woman with tophaceous gout since 10 years ago, presented to our rheumatology clinic. Because of occurring hypersensitivity reactions, allopurinol was discontinued and disease worsened despite administration of colchicine. She was admitted several times due to flare up of gout. Other forms of allopurinol are not available in Iran, so we decided to conduct an allopurinol desensitization protocol with tablets form. Side effects have not been reported yet.
  • Journal title
    Journal of Case Reports in Practice (JCRP)
  • Serial Year
    2014
  • Journal title
    Journal of Case Reports in Practice (JCRP)
  • Record number

    1026366